In a previous study, Tian Tao et al. used MR analysis on plasma proteins from the UKB-PPP to investigate druggable genome linked to endometriosis, identifying FSHB, RSPO3, SEZ6L2, and EPHB4 as potential therapeutic targets [45]. The gene discussed is SEZ6L2; the disease is endometriosis.